Gabriella Chauca Strand
-
Cancer Drugs Reimbursed with Limited Evidence on Overall Survival and Quality of Life: Do Follow-Up Studies Confirm Patient
Benefits?
Gabriella Chauca Strand, Naimi Johansson, Niklas Jakobsson, Carl Bonander, Mikael Svensson
Clinical drug investigation - 2023 -
Assessment of the clinical and cost-effectiveness evidence in the reimbursement decisions of new cancer
drugs
Gabriella Chauca Strand, Carl Bonander, N. Jakobsson, Naimi Johansson, Mikael Svensson
ESMO Open - 2022